ADULT ACUTE MYELOID LEUKEMIA WITH T(8;21)(Q22;Q22)

Clinical trials for ADULT ACUTE MYELOID LEUKEMIA WITH T(8;21)(Q22;Q22) explained in plain language.

Never miss a new study

Get alerted when new ADULT ACUTE MYELOID LEUKEMIA WITH T(8;21)(Q22;Q22) trials appear

Sign up with your email to follow new studies for ADULT ACUTE MYELOID LEUKEMIA WITH T(8;21)(Q22;Q22), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1 Completed 1

New drug duo targets Tough-to-Treat leukemia

Disease control Completed

This study tested whether combining two drugs, sirolimus and azacitidine, could help control high-risk myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML) in adults. The trial enrolled 57 patients whose cancer had returned or who could not tolerate standard high-dose c…

Matched conditions: ADULT ACUTE MYELOID LEUKEMIA WITH T(8;21)(Q22;Q22)

Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control

Last updated Apr 01, 2026 14:41 UTC

ADULT ACUTE MYELOID LEUKEMIA WITH T(8;21)(Q22;Q22)

Get alerted when new ADULT ACUTE MYELOID LEUKEMIA WITH T(8;21)(Q22;Q22) trials appear

New drug duo targets Tough-to-Treat leukemia